Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Altria to sell down stake in AB InBev

(Sharecast News) - Trading in Anheuser-Busch InBev was temporarily suspended on Thursday, after Marlboro maker Altria Group announced plans to sell down its stake in the brewing giant. The US tobacco firm, which owns around 10% of AB InBev, said it planned to sell 35m of the 197m shares it currently holds.

Based on the last closing price, the sale is understood to be worth around $2.26bn, according to Reuters.

Billy Gifford, Altria chief executive, said: "As good stewards of shareholder capital, we consistently review options to unlock the value of our investment, and we believe this is an opportunistic transaction that realises a portion of the substantial return on our long-term investment.

"Over the decades of our ownership, the beer investment has provided significant income and cash returns and supported our strong balance sheet.

"Our continued investment reflects ongoing confident in AB InBev."

Announcing the decision in a brief statement late on Wednesday, Altria said it planned to sell some of the American depositary shares in the US as well as conducting a private placement for the Belgian brewer's ordinary shares in Europe and the UK.

AB InBev, the world's largest brewer, has also agreed to repurchase $200m of ordinary shares from Altria upon completion of the offering.

As at 1100 GMT, Altria's shares were flat in pre-marking trading, while AB InBev's US-traded shares were down 3%.

Its European shares were suspended on the request of Belgium's Financial Services and Markets Authority. AB InBev said the regulator had requested that trading be temporarily paused until pricing details were released, likely later on Thursday.

AB InBev's brands include Stella Artois, Corona and Budweiser.

Share this article

Related Sharecast Articles

Goldman Sachs downgrades SSP to 'sell', prefers WH Smith
(Sharecast News) - Goldman Sachs downgraded SSP on Monday to 'sell' from 'neutral' "on a relative basis" as it took a look at European travel concessions.
UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.